» Articles » PMID: 1665372

Physiological Changes Due to Age. Pharmacodynamic Changes of Drug Action and Implications for Therapy

Overview
Journal Drugs Aging
Specialties Geriatrics
Pharmacology
Date 1991 Sep 1
PMID 1665372
Citations 24
Authors
Affiliations
Soon will be listed here.
Abstract

The elderly respond differently to drugs than do younger people. Their physiological response is much more variable, and predictability of drug action is much less certain. When all non-pharmacological factors and age-associated pharmacokinetics are taken into account, there is still no full explanation of the potentially altered drug action and increased drug toxicity observed in the elderly. It is only relatively recently that age-associated physiological changes (primary age changes), their interplay with age-associated pathophysiological changes (secondary age changes) and environmental changes (tertiary age changes) have been studied with regard to the effect of those changes on the pharmacodynamics of drug action. In general, age-associated pharmacodynamic changes, i.e. changes in the type, intensity and duration of drug action, have been associated with changes in receptor function (e.g. altered receptor number and affinity, altered second messenger function, altered cell response), changes in the homeostatic mechanisms, and reduced reserve capacity. It is important to realise that these changes, which can differ greatly among patients, may be responsible for an increased incidence of adverse drug reactions and therapeutic failure. They may also mandate a higher dose in some circumstances, as some organs become less responsive to drug action with age.

Citing Articles

Comparative safety of adding serotonin and norepinephrine reuptake inhibitors (SNRIs) versus nonsteroidal anti-inflammatory drugs (NSAIDs) to short-acting opioids for non-malignant pain in nursing homes.

Liu S, Yuan Y, Baek J, Nunes A, Pawasauskas J, Hume A J Am Geriatr Soc. 2023; 71(11):3390-3402.

PMID: 37530560 PMC: 10834855. DOI: 10.1111/jgs.18519.


Prescription analgesia and adjuvant use by pain severity at admission among nursing home residents with non-malignant pain.

Lapane K, Hume A, Morrison R, Jesdale B Eur J Clin Pharmacol. 2020; 76(7):1021-1028.

PMID: 32363421 PMC: 7306024. DOI: 10.1007/s00228-020-02878-0.


Hospitalization rates during potentially inappropriate medication use in a large population-based cohort of older adults.

Varga S, Alcusky M, Keith S, Hegarty S, Canale S, Lombardi M Br J Clin Pharmacol. 2017; 83(11):2572-2580.

PMID: 28667818 PMC: 5651328. DOI: 10.1111/bcp.13365.


Sulfonylurea use and risk of hip fractures among elderly men and women with type 2 diabetes.

Rajpathak S, Fu C, Brodovicz K, Engel S, Lapane K Drugs Aging. 2015; 32(4):321-7.

PMID: 25825122 DOI: 10.1007/s40266-015-0254-0.


Cutaneous adverse drug reactions in the elderly: a retrospective analysis in Thailand.

Tuchinda P, Chularojanamontri L, Sukakul T, Thanomkitti K, Nitayavardhana S, Jongjarearnprasert K Drugs Aging. 2014; 31(11):815-24.

PMID: 25193784 DOI: 10.1007/s40266-014-0209-x.


References
1.
Vestal R . Drug use in the elderly: a review of problems and special considerations. Drugs. 1978; 16(4):358-82. DOI: 10.2165/00003495-197816040-00004. View

2.
Hitzenberger G, Fitscha P, Beveridge T, Nuesch E, Pacha W . Influence of smoking and age on pharmacokinetics of beta-receptor blockers. Gerontology. 1982; 28 Suppl 1:93-100. DOI: 10.1159/000212576. View

3.
BENDER A . PHARMACOLOGIC ASPECTS OF AGING: A SURVEY OF THE EFFECT OF INCREASING AGE ON DRUG ACTIVITY IN ADULTS. J Am Geriatr Soc. 1964; 12:114-34. DOI: 10.1111/j.1532-5415.1964.tb00344.x. View

4.
Schmucker D, Daniels C . Aging, gastrointestinal infections, and mucosal immunity. J Am Geriatr Soc. 1986; 34(5):377-84. DOI: 10.1111/j.1532-5415.1986.tb04321.x. View

5.
GEOKAS M, HAVERBACK B . The aging gastrointestinal tract. Am J Surg. 1969; 117(6):881-92. DOI: 10.1016/0002-9610(69)90078-6. View